Sequenom (SQNM) announces a $100M private offering of convertible senior notes due 2017, with a...
Sequenom (SQNM) announces a $100M private offering of convertible senior notes due 2017, with a 30-day option to purchase up to an additional $20M to cover over-allotments. The company plans to use the proceeds to fund the commercialization of its MaterniT21 PLUS laboratory-developed test, as well as for R&D, capital expenditures, working capital and general administrative expenses. Shares -7.5% AH.
From other sites
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs